ALPMF
Astellas Pharma, Inc.After hours13.10−2.20 −14.38%USD
OTC Markets OTCPK · as of Oct 13, 16:00 ET · 15m delay
Open
15.00
Prev close
15.30
Day range
15.0015.00
52-week range
9.8517.85
Volume
3410.06×
Mkt cap
23.49B
P/E ttm
9.92
Fwd P/E
29.77
EPS ttm
1.32
Div yield
3.85%
Earnings
Nov 4, 2026
From 52w high
−26.61%
ALPMF earnings and estimates
ALPMF Next Report
Yahoo Finance · Nasdaq
Report date
Wed, Nov 4
After the close
EPS consensus
$—
EPS growth vs year ago
—
Revenue consensus
$594.09B
+13.3% vs year ago
Options-implied move
—
no expiry soon after the report
Past 0 reactions
—
EPS: Actual vs Estimate
No reported quarters.
Price Reaction
close before → close after the report
No reported quarters.
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | — | — | — | $594.09B | +13.3% | — — | — — | 0 / 0 |
| Next quarter Dec 2026 | — | — | — | $616.88B | +8.0% | — — | — — | 0 / 0 |
| Current year Mar 2027 | — | — | — | $2.37T | +166.4% | — — | — — | 0 / 0 |
| Next year Mar 2028 | — | — | — | $2.20T | −6.9% | — — | — — | 0 / 0 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.